BioCentury | Jul 2, 2001
Clinical News

SuperGen preclinical data

...circulating glucose and triglyceride levels. SUPG obtained rights to DHEA phosphocholine through its acquisition of Amur Pharmaceuticals Inc....
BioCentury | Jun 29, 1998
Clinical News

Amur Pharmaceuticals preclinical data

...increased to control levels. Results were presented at the Endocrine Society meeting in New Orleans. Amur Pharmaceuticals Inc....
BioCentury | Sep 2, 1997
Company News

Amur Pharmaceuticals other research news

...kidney function, and the company is investigating the therapeutic potential of amurol in those areas. Amur Pharmaceuticals Inc....
BioCentury | Jun 30, 1997
Company News

Amur Pharmaceuticals other research news

...up, the company said, it will pursue development of a replacement therapy with the protein. Amur Pharmaceuticals Inc....
BioCentury | Jun 16, 1997
Clinical News

Amur Pharmaceuticals preclinical data

...hours, while digoxin had no effect on blood pressure when administered in the same way. Amur Pharmaceuticals Inc....
BioCentury | Jun 16, 1997
Clinical News

Amur Pharmaceuticals preclinical data

...hasn't been seen in clinical trials due to its short circulation half-life, the company said. Amur Pharmaceuticals Inc....
Items per page:
1 - 6 of 6
BioCentury | Jul 2, 2001
Clinical News

SuperGen preclinical data

...circulating glucose and triglyceride levels. SUPG obtained rights to DHEA phosphocholine through its acquisition of Amur Pharmaceuticals Inc....
BioCentury | Jun 29, 1998
Clinical News

Amur Pharmaceuticals preclinical data

...increased to control levels. Results were presented at the Endocrine Society meeting in New Orleans. Amur Pharmaceuticals Inc....
BioCentury | Sep 2, 1997
Company News

Amur Pharmaceuticals other research news

...kidney function, and the company is investigating the therapeutic potential of amurol in those areas. Amur Pharmaceuticals Inc....
BioCentury | Jun 30, 1997
Company News

Amur Pharmaceuticals other research news

...up, the company said, it will pursue development of a replacement therapy with the protein. Amur Pharmaceuticals Inc....
BioCentury | Jun 16, 1997
Clinical News

Amur Pharmaceuticals preclinical data

...hours, while digoxin had no effect on blood pressure when administered in the same way. Amur Pharmaceuticals Inc....
BioCentury | Jun 16, 1997
Clinical News

Amur Pharmaceuticals preclinical data

...hasn't been seen in clinical trials due to its short circulation half-life, the company said. Amur Pharmaceuticals Inc....
Items per page:
1 - 6 of 6